Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 09, 2026
NTST Stock: Can NETSTREIT Reach the $25 Target (+14% Upside)?

NTST Stock: Can NETSTREIT Reach the $25 Target (+14% Upside)?

Key Takeaways

  • $25 price target represents the highest analyst target for NTST, implying roughly 14% upside from recent trading levels near $21.92.
  • Strong acquisition momentum and a raised 2026 investment outlook of $550–$650 million support the bullish case, driven by high-credit-quality, necessity-based retail tenants.
  • Extremely high short interest — the highest among mid- and large-cap U.S. REITs at over 33% — creates both a potential short-squeeze catalyst and a significant risk if fundamentals weaken.
  • The 52-week high near $22.47 represents a critical resistance level; breaking above it is an essential first step before any sustained move toward $25.
  • Investors should weigh persistent equity dilution, a premium valuation, and interest-rate sensitivity against accelerating acquisition volume and growing dividend payouts.

Why the $25 Target Matters

The $25 price target has gained prominence after several major Wall Street firms raised their outlooks on NTST, a Dallas-based real estate investment trust (REIT) specializing in single-tenant, net-leased retail properties. Cantor Fitzgerald boosted its target to $25 in late July 2026 following strong second-quarter results, while BMO Capital previously set a matching $25 objective, both citing the company's robust investment pipeline and tenant credit profile. With the stock trading around $21.92 and already up roughly 27% year-to-date, the question is whether NTST can clear its 52-week high of $22.47 and sustain a rally toward the $25 mark.

NETSTREIT at a Glance

NETSTREIT Corp. is an internally managed REIT that acquires, owns, and manages a diversified portfolio of single-tenant retail properties subject to long-term, triple-net leases. Under this structure, tenants bear responsibility for property-level expenses including taxes, insurance, and maintenance, producing predictable income streams with minimal landlord obligations. The portfolio focuses on e-commerce-resistant, necessity-based retail sectors such as quick-service restaurants, convenience stores, drug stores, auto parts, and discount retailers across 45 states. Founded in 2019 and publicly listed in 2020, the company operates with a relatively lean team of approximately 29 employees. I also checked this using Tickeron’s AI Screener to see how NTST compares to others in the industry.

Growth Drivers in Focus

NETSTREIT's acquisition engine remains the most powerful bullish argument. In the first quarter of 2026, the company deployed approximately $239 million in gross investments at a blended cash yield of 7.5%, prompting management to raise full-year net investment guidance to a range of $550 million to $650 million. The company maintains a 99.9% occupancy rate, and revenue grew 25% year-over-year in the most recent quarter. Strong institutional backing from major holders such as Vanguard Real Estate ETF, Cohen & Steers, and Principal Funds signals confidence in the strategy.

The dividend narrative also supports the bull case. NETSTREIT raised its quarterly payout to $0.2250 per share, reflecting an annualized yield above 4% at current prices. Combined with accelerating adjusted funds from operations (AFFO), which management explicitly raised in its 2026 outlook, the income-growth profile offers a compelling argument for REIT-focused investors seeking total return. Additionally, 16 of 20 analysts rate the stock a Buy, and the consensus price target has steadily climbed from roughly $18 a year ago to approximately $22.68 today. From what I see, the AI Trend Prediction Engine on Tickeron aligns with this upward bias in the near term.

Risks and Headwinds

The most conspicuous risk is the stock's extraordinarily high short interest, reported at 33.72% — the highest among mid- and large-cap U.S. REITs. While elevated short interest can fuel powerful rallies if shorts are forced to cover, it also reflects deep skepticism about the company's acquisition-driven growth model and whether it can be sustained without excessive equity dilution. NETSTREIT has repeatedly tapped equity markets through at-the-market (ATM) offerings, raising over $236 million in early 2026 alone. Each issuance dilutes existing shareholders, creating a headwind for per-share metrics even as total revenue expands.

Valuation presents another hurdle. The stock trades at a forward price-to-earnings (P/E) ratio near 54 and a trailing P/E above 156, pricing in aggressive growth expectations. The company's Q2 2026 earnings per share (EPS) of $0.06 missed consensus estimates of $0.08, and revenue is projected to edge lower sequentially despite strong occupancy, likely due to the timing of acquisitions and rent commencements. Any further earnings disappointments could give short sellers fresh ammunition. Scotiabank lowered its target to $22 in June 2026, and Wells Fargo previously cut its target to $20, underscoring that not all analysts are aligned with the most optimistic forecasts.

Key Technical Levels to Watch

The 52-week high of $22.47 serves as the immediate resistance level that must be convincingly breached before $25 enters realistic reach. The stock has tested this zone multiple times and continues to trade near the upper boundary of its annual range. The 50-day moving average near $20.68 and the 200-day moving average near $19.96 provide underlying support, suggesting the intermediate-term uptrend remains structurally intact. If the stock can break above $22.47 on strong volume, the psychological round number of $25 becomes the next logical objective, representing roughly 14% total upside from current levels. I'm watching this closely as the next few sessions could be telling.

Broader Market Context

As a net-lease retail REIT, NTST is inherently sensitive to interest-rate movements and broader capital-market conditions. Higher financing costs can compress acquisition spreads and reduce the attractiveness of leveraged property purchases. However, the company's focus on necessity retail tenants provides a defensive buffer during economic downturns, as consumers continue visiting drug stores, auto-parts retailers, and quick-service restaurants regardless of the macroeconomic climate. The net-lease REIT subsector received an Overweight upgrade from Scotiabank in mid-2026, reflecting improving sentiment about the group's valuation-versus-growth profile.

Final Assessment

A move to $25 for NTST stock is ambitious but not unrealistic. The company's accelerating acquisition pace, growing dividend, near-perfect occupancy, and strong analyst consensus provide a credible foundation. However, the path is far from guaranteed. The stock must first break decisively above its 52-week high of $22.47, all while managing the twin challenges of elevated short interest and ongoing equity dilution. For the $25 target to materialize, investors would need to see continued execution on the $550–$650 million investment plan, stabilization or improvement in quarterly EPS, and a broader macro environment that remains supportive of REIT valuations. The pieces are on the table, but the next few earnings reports and acquisition announcements will likely determine whether the bulls or the skeptics prevail.

How I Use AI Daily Buy/Sell Signals

When analyzing names like NTST, I turn to Tickeron’s AI Daily Buy/Sell Signals for real-time insights. The tool scans thousands of stocks and ETFs to deliver actionable Buy, Sell, or Hold alerts based on shifting technical and fundamental conditions. It helps me stay on top of acquisition updates, earnings moves, and sentiment changes without getting lost in the noise.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations
Related Ticker: NTST

Contributor

<p>Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years&nbsp;developing&nbsp;his proprietary trading and quantitative algorithms (now Tickeron&rsquo;s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional,&nbsp;sophisticated stock market analysis capabilities to retail investors via&nbsp;an easy-to-use interface.</p>


NTST in upward trend: price may jump up because it broke its lower Bollinger Band on August 07, 2026

NTST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 47 cases where NTST's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NTST advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 252 cases where NTST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NTST moved out of overbought territory on July 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NTST as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NTST turned negative on July 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

NTST moved below its 50-day moving average on August 07, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NTST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.336) is normal, around the industry mean (2.992). NTST's P/E Ratio (147.786) is considerably higher than the industry average of (42.082). NTST's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (3.422). Dividend Yield (0.042) settles around the average of (0.045) among similar stocks. P/S Ratio (9.390) is also within normal values, averaging (7.303).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NTST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock worse than average.

Notable companies

The most notable companies in this group are Simon Property Group (NYSE:SPG), Tanger (NYSE:SKT).

Industry description

A real estate investment trust (REIT) is a company any that owns, and in most cases, operates, income-producing real estate – ranging from office and apartment buildings to warehouses, hospitals, shopping centers, hotels and timberlands. Some REITs are involved in financing real estate. Equity REITs invest in and own properties, while mortgage REITs own and invest in property mortgages. REITs are required by law to pay out at least 90% of their annual taxable income (excluding capital gains) to shareholders in the form of dividends. Some REITs could be more cyclical than others; for example, when an economy is undergoing a recession, hotel REITs could be more vulnerable, compared to say healthcare REIT given that healthcare needs are less likely to depend on economic cycles. American Tower Corporation, Prologis, Inc. and Crown Castle International Corp are some of the biggest REIT companies in the U.S.

Market Cap

The average market capitalization across the Real Estate Investment Trusts Industry is 9.36B. The market cap for tickers in the group ranges from 51.9K to 243.79B. COFRF holds the highest valuation in this group at 243.79B. The lowest valued company is PDNLB at 51.9K.

High and low price notable news

The average weekly price growth across all stocks in the Real Estate Investment Trusts Industry was -4%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 6%. ALX experienced the highest price growth at 9%, while WHLR experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Real Estate Investment Trusts Industry was 18%. For the same stocks of the Industry, the average monthly volume growth was 57% and the average quarterly volume growth was 35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 65
Price Growth Rating: 52
SMR Rating: 74
Profit Risk Rating: 59
Seasonality Score: -43 (-100 ... +100)
View a ticker or compare two or three
NTST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a real estate investment trust (REIT) that engages in the acquisition and management of portfolio of single-tenant, retail commercial real estate subject to long-term net leases

Industry RealEstateInvestmentTrusts

Profile
Details
Industry
N/A
Address
2021 McKinney Avenue
Phone
+1 972 200-7100
Employees
28
Web
https://www.netstreit.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
NTST Stock: Can NETSTREIT Reach the $25 Target (+14% Upside)?